The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,401
Sort by:
Global Biofilms Treatment Market Size Study & Forecast, by Products (Debridement Equipment, Gauze, Dressing, Gel, Ointment) by Wound Type (Traumatic, Surgical, Open, Diabetic Foot, Venous Leg Ulcer & Burns) by End User (Hospital, ASCs, Wound Care Centers, Homecare) and Regional Forecasts 2025-2035
US$ 3,750.00
The Global Biofilms Treatment Market is valued at approximately USD 2.17 billion in 2024 and is projected to grow at a CAGR of 7.90% during the forecast period 2025-2035. Biofilms treatments are speci...
August 2026
285 pages
Hematuria Market - A Global and Regional Analysis: Focus on Drug Class, Route of Administration, Country and Region - Analysis and Forecast, 2025-2035
US$ 4,900.00
Hematuria, defined as the presence of blood in urine, is a symptom rather than a standalone disease, arising from diverse etiologies such as infections, kidney stones, glomerular disorders, and genito...
August 2026
-
